期刊
TRANSLATIONAL LUNG CANCER RESEARCH
卷 5, 期 6, 页码 720-726出版社
AME PUBL CO
DOI: 10.21037/tlcr.2016.11.06
关键词
Lymphoepithelioma-like carcinoma of the lung (LELC of the lung); immunotherapy; nivolumab
In recent years, significant advances have been made in cancer immunotherapy. Here, we present the first report of a patient with lymphoepithelioma-like carcinoma (LELC) of the lung, an Epstein-Barr virus (EBV)-associated lung cancer, who was treated with nivolumab, a fully human IgG4 anti-PD-1 monoclonal antibody. We also carry out a focused review to identify and examine studies of LELC of the lung in the literature. This case report highlights the need to further assess the role of immune checkpoint inhibitors in LELC of the lung.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据